US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk
US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk

The FDA and CDC officially lifted the pause that was put in place last Tuesday, August 13, despite concerns over a potential link to rare and deadly blood clots.